Colchicine therapy in Behçet's syndrome--a report of five cases.
Five patients with Behçet's syndrome of varying duration were treated with colchicine (500 micrograms b.i.d.). All improved clinically and one has remained clear for 1 year after cessation of therapy, although in one patient who had neurological symptoms, paraesthesiae have persisted throughout treatment.
Muzulu
S I
SI
Walton
S
S
Keczkes
K
K
D000328:Adult; D000368:Aged; D001528:Behcet Syndrome / Q000188:drug therapy*; D003078:Colchicine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male
D003078:Colchicine